Albuminuria and the risk of incident stroke and stroke types in older adults

Background: The kidney biomarker that best reflects risk of stroke is unknown. We sought to evaluate the association of stroke with 3 kidney biomarkers: albuminuria, cystatin C, and glomerular filtration rate. Methods: These 3 biomarkers were determined in 3,287 participants without history of stroke from the Cardiovascular Health Study, a longitudinal cohort study of men and women age 65 years and older from 4 US communities. The biomarkers were albuminuria ascertained using urinary albumin-to-creatinine ratio (UACR) from morning spot urine, creatinine-based estimated glomerular filtration rate (eGFR), and cystatin C. Outcomes were incident stroke (any, ischemic, or hemorrhagic) during follow-up between 1996 and 2006. Results: A total of 390 participants had an incident stroke: 81% ischemic, 12% hemorrhagic, and 7% unclassified. In adjusted Cox regression models, UACR was more strongly related to any stroke, ischemic stroke, and hemorrhagic stroke than eGFR and cystatin C. The hazard ratio (HR) of any stroke comparing the top to bottom quintile of UACR was 2.10 (95% confidence interval [CI] 1.47–3.00), while HR for eGFR was 1.29 (95% CI 0.91–1.84) and for cystatin C was 1.22 (95% CI 0.85–1.74). When considering clinically relevant categories, elevated UACR was associated with increased hazard of any stroke and ischemic stroke regardless of eGFR or cystatin C categories. Conclusions: UACR was the kidney biomarker most strongly associated with risk of incident stroke. Results in this elderly cohort may not be applicable to younger populations. These findings suggest that measures of glomerular filtration and permeability have differential effects on stroke risk.

[1]  K. Nakashima,et al.  [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[2]  L. Price,et al.  Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  C. Jack,et al.  Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships , 2008, Journal of the Neurological Sciences.

[4]  J. Danziger Importance of low-grade albuminuria. , 2008, Mayo Clinic proceedings.

[5]  B. Astor,et al.  Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. , 2008, American journal of epidemiology.

[6]  C. Schmid,et al.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  C. DeCarli,et al.  Chronic Kidney Disease Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study (NOMAS) , 2007, Stroke.

[8]  R. Hui,et al.  Cystatin C, Associated With Hemorrhagic and Ischemic Stroke, Is a Strong Predictor of the Risk of Cardiovascular Events and Death in Chinese , 2007, Stroke.

[9]  A. Hofman,et al.  Decreased Glomerular Filtration Rate Is a Risk Factor for Hemorrhagic But Not for Ischemic Stroke: The Rotterdam Study , 2007, Stroke.

[10]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[11]  Takeo Kato,et al.  Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects , 2007, Journal of the Neurological Sciences.

[12]  B. Kestenbaum,et al.  Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease , 2006, Annals of Internal Medicine.

[13]  L. Kuller,et al.  The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health Study. , 2006, Atherosclerosis.

[14]  Anne Newman,et al.  Cystatin C and subclinical brain infarction. , 2005, Journal of the American Society of Nephrology : JASN.

[15]  D. Levy,et al.  Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals: The Framingham Heart Study , 2005, Circulation.

[16]  D. Siscovick,et al.  Cystatin C and the risk of death and cardiovascular events among elderly persons. , 2005, The New England journal of medicine.

[17]  B. Psaty,et al.  Cystatin-C and mortality in elderly persons with heart failure. , 2005, Journal of the American College of Cardiology.

[18]  D. E. Busby,et al.  Comparison of Commonly Used Assays for the Detection of Microalbuminuria , 2004, Journal of clinical hypertension.

[19]  R. Klein,et al.  The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  M. Nieminen,et al.  Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. , 2004, Annals of internal medicine.

[21]  M. Nieminen,et al.  Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study , 2003, Annals of Internal Medicine.

[22]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Circulation.

[23]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[24]  S. Romundstad,et al.  Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[26]  J. Coresh,et al.  Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. , 2003, Kidney international.

[27]  A. Słowik,et al.  Microalbuminuria in Nondiabetic Patients with Acute Ischemic Stroke: Prevalence, Clinical Correlates, and Prognostic Significance , 2002, Cerebrovascular Diseases.

[28]  S. Yusuf,et al.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.

[29]  C. Furberg,et al.  Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study , 2001, Neurology.

[30]  David Roth,et al.  A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .

[31]  M. Schroll,et al.  Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. , 2000, Hypertension.

[32]  M. Rodríguez-Moran,et al.  Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus. , 1999, Stroke.

[33]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[34]  H. Gerstein,et al.  The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. , 1997, Archives of internal medicine.

[35]  M. Fantone,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.

[36]  B M Psaty,et al.  Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. , 1991, Stroke.

[37]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[38]  P M Rautaharju,et al.  Methodology of ECG Interpretation in the Dalhousie Program; NOVACODE ECG Classification Procedures for Clinical Trials and Population Health Surveys , 1990, Methods of Information in Medicine.

[39]  Jasmin A. Tiro,et al.  Non-Insulin-Dependent Diabetes Mellitus , 2006 .